Advertisement

Dopamin und Noradrenalin im Liquor cerebrospinalis Schizophrener

  • W. F. Gattaz
  • P. Riederer
  • G. Reynolds
  • D. Gattaz
  • H. Beckmann
Conference paper

Zusammenfassung

Häufig wurde ein Zusammenhang zwischen der Ätiologie endogener Psychosen und den Katecholaminen Dopamin (DA) und Noradrenalin (NA) angenommen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Angrist BM, Gershon S (1970) The phenomenology of experimentally induced amphetamine psychosis: Preliminary observations. Biol Psychiatry 2: 95–107PubMedGoogle Scholar
  2. 2.
    Bartholini G, Stadler H, Gadea-Ciria M, Lloyd KG (1976) The use of the push-pull cannula to estimate the dynamics of acetylcholine and catecholamines within various brain areas. Neuropharmacology 15: 515–519PubMedCrossRefGoogle Scholar
  3. 3.
    Bartholini G, Stadler H, Gadea-Ciria M, Lloyd KG (1976) The effect of antipsychotic drugs on the release of neurotransmitters in various brain areas. In: Sedvall G (ed) Antipsychotic drugs: Pharmacodynamics and pharmacokinetics. Pergamon, Oxford, pp 515–522Google Scholar
  4. 4.
    Bird ED, Barnes J, Iversen LL, Spokes EG, Mackay AVP, Shepherd M (1977) Increased brain dopamine and reduced glutamic acid decarboxilase and choline acetyltransferase activity in schizophrenia and related psychoses. Lancet II: 1157–1159CrossRefGoogle Scholar
  5. 5.
    Bird ED, Spokes EG, Iversen LL (1979) Brain norepinephrine and dopamine in schizophrenia. Science 204: 93–94PubMedCrossRefGoogle Scholar
  6. 6.
    Carlsson A (1974) Some aspects of dopamine in the central nervous system. In: McDowell FA, Barbeau A (eds) Advances in neurology, vol 5. Raven, New York, pp 59–68Google Scholar
  7. 7.
    Carlsson A, Lindquist M (1963) Effect of chlorpromazine or haloperidol on formation of 3- methoxytyramine and normetanephrine in mouse brain. Acta Pharm Int 20: 140–144CrossRefGoogle Scholar
  8. 8.
    Connell PH (1958) Amphetamine psychosis. Chapman & Hall, LondonGoogle Scholar
  9. 9.
    Farley IF, Price KS, McCullough E, Deck JHN, Hordynski W, Hornykiewicz O (1978) Norepinephrine in chronic paranoid schizophrenia: Above-normal levels in limbic forebrain. Science 200: 456–458PubMedCrossRefGoogle Scholar
  10. 10.
    Felice LJ, Felice JD, Kissinger PT (1978) Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography. J Neurochem 31: 1461PubMedCrossRefGoogle Scholar
  11. 11.
    Gomes UCR, Shanley BC, Potgieter L, Roux JT (1980) Noradrenergic overactivity in chronic schizophrenia: Evidence based on cerebrospinal fluid noradrenaline and cyclic nucleotide concentrations. Br J Psychiatry 137: 346–351PubMedCrossRefGoogle Scholar
  12. 12.
    Janowsky DS, Risch C (1979) Amphetamine psychosis and psychotic symptoms. Psychopharmaeology 65: 73–77CrossRefGoogle Scholar
  13. 13.
    Lake CR, Sternberg DE, van Kämmen DP et al. (1980) Schizophrenia: Elevated cerebrospinal fluid norepinephrine. Science 207: 331–333PubMedCrossRefGoogle Scholar
  14. 14.
    Siegel S (1975) Nonparametric statistics for the behavioral sciences. McGraw-Hill, New YorkGoogle Scholar
  15. 15.
    Spitzer RL, Endicott J, Robins E (1975) Research diagnostic criteria. New York State Psychiatric Institute, New York (Instrument No 58 )Google Scholar
  16. 16.
    Stadler H, Gadea-Ciria M, Bartholini G (1975) In vivo release of endogenous neurotransmitters in cat limbic regions: Effect of chlorpromazine and of electrical stimulation. Naunyn-Schmiedebergs Arch Pharmacol 288: 1–6PubMedCrossRefGoogle Scholar
  17. 17.
    Stein L, Wise CD (1971) Possible etiology of schizophrenia: Progressive damage to the noradrenergic reward system by 6-hydroxydopamine. Science 171: 1032–1036PubMedCrossRefGoogle Scholar
  18. 18.
    Sternberg DE, van Kämmen DP, Lake CR, Ballenger JC, Marder SR, Bunney WE (1981) The effect of pimozide on CSF norepinephrine in schizophrenia. Am J Psychiatry 138: 1045–1051PubMedGoogle Scholar
  19. 19.
    Wise CD, Stein L (1973) Dopamines-hydroxylase deficits in the brains of schizophrenic patients. Science 181: 344–347PubMedCrossRefGoogle Scholar
  20. 20.
    Wyatt RJ, Schwartz MA, Erdelyi E, Barchas JD (1975) Dopamines-hydroxylase activity in brains of chronic schizophrenic patients. Science 187: 368–370PubMedCrossRefGoogle Scholar
  21. 21.
    Ziegler MG, Lake CR, Wood JH, Brooks BR, Ebert MH (1977) Relationship between norepinephrine in blood and cerebrospinal fluid in the presence of a blood-cerebrospinal fluid barrier for norepinephrine. J Neurochem 28: 677––682PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • W. F. Gattaz
  • P. Riederer
  • G. Reynolds
  • D. Gattaz
  • H. Beckmann

There are no affiliations available

Personalised recommendations